Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
The in vitro study of sitafloxacin against carbapenem-resistant (CR) <i>Acinetobacter baumannii</i> demonstrated activity against most strains of CR <i>A. baumannii</i>, and the combination of colistin and sitafloxacin showed an in vitro synergistic effect against CR <i>...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/11/12/1707 |